Stratifying risk outcomes among adult COVID-19 inpatients with high flow oxygen: The R4 score

BACKGROUND: High flow oxygen therapy (HFO) is a widely used intervention for pulmonary complications. Amid the coronavirus infectious disease 2019 (COVID-19) pandemic, HFO became a popular alternative to conventional oxygen supplementation therapies. Risk stratification tools have been repurposed –a...

Descripción completa

Detalles Bibliográficos
Autores principales: Aguirre-García, G.M., Ramonfaur, D., Torre-Amione, G., Ramírez-Elizondo, M.T., Lara-Medrano, R., Moreno-Hoyos, J.F., Velázquez-Ávila, E.S., Diaz-Garza, C.A., Sanchez-Nava, V.M., Castilleja-Leal, F., Rhoades, G.M., Martínez-Reséndez, M.F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506226/
https://www.ncbi.nlm.nih.gov/pubmed/34728168
http://dx.doi.org/10.1016/j.pulmoe.2021.10.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506226/
https://www.ncbi.nlm.nih.gov/pubmed/34728168
http://dx.doi.org/10.1016/j.pulmoe.2021.10.001

Ejemplares similares